• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适应性免疫细胞是 SARS-CoV-2 诱导发病所必需的。

Adaptive immune cells are necessary for SARS-CoV-2-induced pathology.

机构信息

Department of Microbiology and Immunology, Cornell University, College of Veterinary Medicine, Ithaca, NY 14853, USA.

Department of Microbiology, Cornell University, College of Agriculture and Life Sciences, Ithaca, NY 14853, USA.

出版信息

Sci Adv. 2024 Jan 5;10(1):eadg5461. doi: 10.1126/sciadv.adg5461. Epub 2024 Jan 3.

DOI:10.1126/sciadv.adg5461
PMID:38170764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10775995/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the ongoing global pandemic associated with morbidity and mortality in humans. Although disease severity correlates with immune dysregulation, the cellular mechanisms of inflammation and pathogenesis of COVID-19 remain relatively poorly understood. Here, we used mouse-adapted SARS-CoV-2 strain MA10 to investigate the role of adaptive immune cells in disease. We found that while infected wild-type mice lost ~10% weight by 3 to 4 days postinfection, mice lacking B and T lymphocytes did not lose weight. Infected lungs at peak weight loss revealed lower pathology scores, fewer neutrophils, and lower interleukin-6 and tumor necrosis factor-α in mice. Mice lacking αβ T cells also had less severe weight loss, but adoptive transfer of T and B cells into mice did not significantly change the response. Collectively, these findings suggest that while adaptive immune cells are important for clearing SARS-CoV-2 infection, this comes at the expense of increased inflammation and pathology.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)正在引发与人类发病率和死亡率相关的持续全球大流行。尽管疾病的严重程度与免疫失调相关,但 COVID-19 的炎症发生机制和发病机制仍相对了解甚少。在这里,我们使用小鼠适应的 SARS-CoV-2 株 MA10 来研究适应性免疫细胞在疾病中的作用。我们发现,虽然感染野生型小鼠在感染后 3 至 4 天体重减轻约 10%,但缺乏 B 和 T 淋巴细胞的小鼠体重并未减轻。在体重减轻达到峰值时,感染的肺部显示出较低的病理学评分、较少的中性粒细胞以及较低的白细胞介素 6 和肿瘤坏死因子-α。缺乏 αβ T 细胞的小鼠的体重减轻也不那么严重,但将 T 和 B 细胞过继转移到 小鼠中并没有显著改变反应。总的来说,这些发现表明,虽然适应性免疫细胞对于清除 SARS-CoV-2 感染很重要,但这是以增加炎症和病理学为代价的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/77f256df7437/sciadv.adg5461-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/abe8fb15532d/sciadv.adg5461-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/c63053a06c94/sciadv.adg5461-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/673326216262/sciadv.adg5461-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/77f256df7437/sciadv.adg5461-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/abe8fb15532d/sciadv.adg5461-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/c63053a06c94/sciadv.adg5461-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/673326216262/sciadv.adg5461-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bb/10775995/77f256df7437/sciadv.adg5461-f4.jpg

相似文献

1
Adaptive immune cells are necessary for SARS-CoV-2-induced pathology.适应性免疫细胞是 SARS-CoV-2 诱导发病所必需的。
Sci Adv. 2024 Jan 5;10(1):eadg5461. doi: 10.1126/sciadv.adg5461. Epub 2024 Jan 3.
2
Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.鼠适应的 SARS-CoV-2 MA10 株在 K18-hACE2 小鼠中显示出不同的肺嗜性和加速的病毒复制、神经传播以及肺部宿主反应。
mSphere. 2023 Feb 21;8(1):e0055822. doi: 10.1128/msphere.00558-22. Epub 2023 Feb 2.
3
JAK inhibition during the early phase of SARS-CoV-2 infection worsens kidney injury by suppressing endogenous antiviral activity in mice.在 SARS-CoV-2 感染的早期阶段抑制 JAK 会通过抑制内源性抗病毒活性而使小鼠的肾脏损伤恶化。
Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F931-F941. doi: 10.1152/ajprenal.00011.2024. Epub 2024 Apr 18.
4
Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection.Toll样受体7(TLR7)介导的抗病毒反应可保护小鼠免受致命的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染。
J Virol. 2025 May 20;99(5):e0166824. doi: 10.1128/jvi.01668-24. Epub 2025 Mar 31.
5
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.补体激活参与严重急性呼吸综合征冠状病毒发病机制。
mBio. 2018 Oct 9;9(5):e01753-18. doi: 10.1128/mBio.01753-18.
6
Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice.MA10 鼠适应 SARS-CoV-2 病毒感染诱导标准实验室小鼠神经炎症。
Viruses. 2022 Dec 30;15(1):114. doi: 10.3390/v15010114.
7
A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.一种用于SARS-CoV-2感染的人ACE2基因敲入小鼠模型再现了呼吸系统疾病,但避免了与转基因K18-hACE2模型相关的神经疾病。
mBio. 2025 May 14;16(5):e0072025. doi: 10.1128/mbio.00720-25. Epub 2025 Apr 24.
8
Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.传染性克隆产生的 SARS-CoV-2 可导致感染 K18-Human ACE2 小鼠发生严重肺部疾病。
mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21.
9
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.SARS-CoV-2 引起人类 ACE2 基因敲入小鼠肺部感染但不引起严重疾病。
J Virol. 2022 Jan 12;96(1):e0151121. doi: 10.1128/JVI.01511-21. Epub 2021 Oct 20.
10
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.恒河猴腺病毒 COVID-19 疫苗对小鼠适应 SARS-CoV-2 的保护效力。
J Virol. 2021 Nov 9;95(23):e0097421. doi: 10.1128/JVI.00974-21. Epub 2021 Sep 15.

引用本文的文献

1
Cxcl10 is required for survival during SARS-CoV-2 infection in mice.在小鼠感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)期间,趋化因子Cxcl10是生存所必需的。
bioRxiv. 2024 Oct 1:2024.09.30.613319. doi: 10.1101/2024.09.30.613319.
2
Cxcl10 is protective during mouse-adapted SARS-CoV-2 infection.趋化因子Cxcl10在小鼠适应性严重急性呼吸综合征冠状病毒2感染期间具有保护作用。
J Leukoc Biol. 2025 Mar 14;117(3). doi: 10.1093/jleuko/qiae252.
3
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections.利用T细胞加强针对病毒感染的疫苗研发。

本文引用的文献

1
Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19.γ9δ2 T 细胞是 SARS-CoV-2 复制的有效抑制剂,并在 COVID-19 患者中表现出效应表型。
J Infect Dis. 2024 Jun 14;229(6):1759-1769. doi: 10.1093/infdis/jiae169.
2
COVID-19 infection: an overview on cytokine storm and related interventions.COVID-19 感染:细胞因子风暴及相关干预措施概述。
Virol J. 2022 May 26;19(1):92. doi: 10.1186/s12985-022-01814-1.
3
Establishment of tissue-resident immune populations in the fetus.
Vaccines (Basel). 2024 Apr 29;12(5):478. doi: 10.3390/vaccines12050478.
4
Spectrum of COVID-19 induced liver injury: A review report.新型冠状病毒肺炎所致肝损伤的研究现状:一篇综述报告
World J Hepatol. 2024 Apr 27;16(4):517-536. doi: 10.4254/wjh.v16.i4.517.
胎儿组织驻留免疫群体的建立。
Semin Immunopathol. 2022 Nov;44(6):747-766. doi: 10.1007/s00281-022-00931-x. Epub 2022 May 4.
4
Inflammasome activation in infected macrophages drives COVID-19 pathology.在被感染的巨噬细胞中激活炎症小体导致 COVID-19 病理学。
Nature. 2022 Jun;606(7914):585-593. doi: 10.1038/s41586-022-04802-1. Epub 2022 Apr 28.
5
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation.FcγR 介导的 SARS-CoV-2 感染单核细胞激活炎症反应。
Nature. 2022 Jun;606(7914):576-584. doi: 10.1038/s41586-022-04702-4. Epub 2022 Apr 6.
6
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.一种 TMPRSS2 抑制剂可作为泛 SARS-CoV-2 的预防和治疗药物。
Nature. 2022 May;605(7909):340-348. doi: 10.1038/s41586-022-04661-w. Epub 2022 Mar 28.
7
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues.恒河猴轻度感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与组织中抗原特异性T细胞反应之前的病毒控制有关。
Sci Immunol. 2022 Mar 10:eabo0535. doi: 10.1126/sciimmunol.abo0535.
8
Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections.γδ T 细胞及其在 COVID-19 病毒感染中的作用。
Front Immunol. 2021 Oct 29;12:741218. doi: 10.3389/fimmu.2021.741218. eCollection 2021.
9
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
10
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2.SARS-CoV-2 小鼠模型中病毒清除和保护的适应性免疫决定因素。
Sci Immunol. 2021 Oct 15;6(64):eabl4509. doi: 10.1126/sciimmunol.abl4509. Epub 2021 Sep 2.